Nexien BioPharma, Inc. NXEN OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

Es gab 50 kürzliche Insider-Transaktionen für Nexien BioPharma, Inc. (NXEN), darunter 40 Käufe und 7 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $1.13M und die gesamten Insider-Verkäufe auf $1.28M.

Bedeutende Insider mit kürzlicher Aktivität umfassen Greenberg Richard S, Wasoff Evan L, Goldfarb Robert I. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.

Insider-Transaktionen — NXEN

Datum	Name	Funktion	Transaktionsart	Aktien	Ø Preis	Wert	Gehaltene Aktien
2024-05-23	Greenberg Richard S	10 Percent Owner, Officer: Chief Executive Officer	RSU-Zuteilung	1,000,000	-	-	7,185,193
2024-05-23	Wasoff Evan L	Chief Financial Officer	RSU-Zuteilung	2,000,000	-	-	6,500,000
2023-10-31	Greenberg Richard S	10 Percent Owner, Officer: Chief Executive Officer	RSU-Zuteilung	250,000	-	-	6,185,193
2023-10-31	Wasoff Evan L	Chief Financial Officer	RSU-Zuteilung	250,000	-	-	4,500,000
2023-07-25	Goldfarb Robert I	Chief Operating Officer	RSU-Zuteilung	250,000	-	-	2,278,000
2023-07-25	Greenberg Richard S	10 Percent Owner, Officer: Chief Executive Officer	RSU-Zuteilung	250,000	-	-	5,935,193
2023-07-25	Wasoff Evan L	Chief Financial Officer	RSU-Zuteilung	250,000	-	-	4,250,000
2023-04-01	Goldfarb Robert I	Chief Operating Officer	RSU-Zuteilung	250,000	-	-	2,028,000
2023-04-01	Greenberg Richard S	10 Percent Owner, Officer: Chief Executive Officer	RSU-Zuteilung	250,000	-	-	5,685,193
2023-04-01	Wasoff Evan L	Chief Financial Officer	RSU-Zuteilung	250,000	-	-	4,000,000
2023-01-17	Greenberg Richard S	Chief Executive Officer	RSU-Zuteilung	250,000	-	-	5,435,193
2023-01-17	Wasoff Evan L	Chief Financial Officer	RSU-Zuteilung	250,000	-	-	3,750,000
2023-01-17	Goldfarb Robert I	Chief Operating Officer	RSU-Zuteilung	250,000	-	-	1,778,000
2022-10-17	Goldfarb Robert I	Chief Operating Officer	RSU-Zuteilung	250,000	-	-	1,528,800
2022-10-17	Greenberg Richard S	Chief Executive Officer	RSU-Zuteilung	250,000	-	-	5,185,193
2022-10-17	Wasoff Evan L	Chief Financial Officer	RSU-Zuteilung	250,000	-	-	3,500,000
2022-07-27	Goldfarb Robert I	Chief Operating Officer	RSU-Zuteilung	250,000	-	-	1,278,800
2022-07-27	Wasoff Evan L	Chief Financial Officer	RSU-Zuteilung	250,000	-	-	3,250,000
2022-07-27	Greenberg Richard S	10 Percent Owner, Officer: Chief Executive Officer	RSU-Zuteilung	250,000	-	-	4,935,193
2022-04-20	Wasoff Evan L	Chief Financial Officer	RSU-Zuteilung	250,000	-	-	3,000,000
2022-04-20	Greenberg Richard S	10 Percent Owner, Officer: Chief Executive Officer	RSU-Zuteilung	250,000	-	-	4,685,193
2022-01-27	Greenberg Richard S	10 Percent Owner, Officer: Chief Executive Officer	RSU-Zuteilung	250,000	-	-	4,435,192
2022-01-27	Wasoff Evan L	Chief Financial Officer	RSU-Zuteilung	250,000	-	-	2,750,000
2021-11-29	Greenberg Richard S	10 Percent Owner, Officer: Chief Executive Officer	RSU-Zuteilung	500,000	-	-	4,185,192
2021-11-29	Wasoff Evan L	Chief Financial Officer	RSU-Rückgabe	500,000	-	-	2,500,000
2021-06-07	Snider Lindy	Director	RSU-Zuteilung	250,000	-	-	730,000
2021-04-01	Greenberg Richard S	10 Percent Owner, Officer: Chief Executive Officer	RSU-Zuteilung	1,000,000	-	-	3,685,192
2021-04-01	Wasoff Evan L	Chief Financial Officer	RSU-Zuteilung	1,000,000	-	-	2,000,000
2020-11-24	Greenberg Richard S	10 Percent Owner, Officer: Chief Executive Officer	RSU-Zuteilung	-	$0.04	-	-
2020-08-19	Goldfarb Robert I	Chief Operating Officer	RSU-Zuteilung	1,000,000	$0.08	$80K	1,000,000
2020-08-19	Goldfarb Robert I	Chief Operating Officer	RSU-Zuteilung	1,000,000	$0.08	$80K	1,000,000
2020-08-19	Greenberg Richard S	Chief Executive Officer	RSU-Zuteilung	2,500,000	$0.08	$200K	2,500,000
2020-08-19	Wasoff Evan L	Chief Financial Officer	RSU-Zuteilung	1,500,000	$0.08	$120K	1,500,000
2020-08-19	Goldfarb Robert I	Chief Operating Officer	RSU-Zuteilung	1,000,000	$0.08	$80K	1,000,000
2020-08-19	Goldfarb Robert I	Chief Operating Officer	RSU-Zuteilung	1,000,000	-	-	1,000,000
2020-08-19	Goldfarb Robert I	Chief Operating Officer	RSU-Zuteilung	1,000,000	-	-	1,000,000
2020-08-12	Greenberg Richard S	Chief Executive Officer	Umwandlung (Kauf)	1,800,880	$0.01	$25.21K	2,688,880
2020-08-12	Greenberg Richard S	Chief Executive Officer	Umwandlung (Kauf)	1,797,192	$0.01	$25.16K	2,685,192
2019-11-22	Friedland Jeffrey	Officer	Schenkung (gegeben)	228,800	-	-	-
2019-04-04	Friedland Jeffrey	Officer	Informierter Verkauf	5,000,000	$0.09	$425K	19,000,000
2019-04-04	Kanativa Usa Inc.	10 Percent Owner	Informierter Verkauf	5,000,000	$0.09	$425K	19,000,000
2019-04-04	Kanativa Inc.	10 Percent Owner	Unbekannt	-	-	-	24,000,000
2019-04-04	Kanativa Inc.	10 Percent Owner	Informierter Verkauf	5,000,000	$0.09	$425K	19,000,000
2019-04-01	Bankier Alain D	Officer	Unbekannt	-	-	-	-
2018-10-26	Greenberg Richard S	EVP	RSU-Zuteilung	100,000	$0.66	$65.5K	100,000
2018-10-26	Bankier Alain D	Executive Chairman	RSU-Zuteilung	500,000	$0.66	$327.5K	500,000
2018-10-26	Wasoff Evan L	Chief Financial Officer	RSU-Zuteilung	200,000	$0.66	$131K	200,000
2018-10-26	Aceto Joseph F	VP Legal & Ip Counsel	Veräußerung	-	-	-	1,045,000
2018-10-26	Wasyl Alexander Michael	Chief Executive Officer	Veräußerung	-	-	-	5,445,000
2018-10-26	Reeh Jeremy Robert	VP Translational Research	Veräußerung	-	-	-	1,925,000

■ Informativ — Transaktion am offenen Markt (bedeutendste) ■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung ■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting ■ Neutral — Schenkung, Treuhand, Verfall